What's New
Register by December 20 for the Best Pricing
The 2022 Annual Meeting will be held in-person at the Gaylord Palms Resort and Convention Center near Orlando. Select sessions will also be available in a hybrid format, allowing virtual participation.
Read More
Registration is Now Open!
Join us in Clearwater, Florida on November 18-19 for the SMFM Practice Management Conference. This year's conference will provide an opportunity to learn more about the business of MFM with case studies and best practices, processes for continuous quality improvement, and networking opportunities with leaders in the field.
Read More
New Online Learning Offerings
Reinforce your knowledge of SMFM's clinical recommendations with this webinar series. Current offerings include: Hepatitis C in Pregnancy, Activity Restriction, Thromboembolism Prophylaxis for Cesarean Delivery, and Intrahepatic Cholestasis of Pregnancy.
Read MoreRecent News
- SMFM Partners with RCOG and USASP to File an Amicus Brief in Dobbs v. Jackson Women’s Health Organization
- Remember SMFM Past President, Dr. James Martin
- SMFM Calls on Congress to Pass Legislation that Would Safegaurd Abortion Care
- SMFM Supports NIH Treatment Guidelines for COVID-19, Do Not Withhold COVID-19 Therapies for Pregnant People
- SMFM Supports the Inclusion of Pregnant People in COVID-19 Vaccine Mandates
- Statement of Strong Medical Consensus for Vaccination of Pregnant Individuals Against COVID-19
- SMFM and ACOG Support COVID-19 Vaccination for Pregnant People
- SMFM Supports the Women's Health Protection Act
- Remembering Dr. Jeffrey Greenspoon
- SMFM Thanks the FDA for Lifting the In-Person Dispensing Requirements for Mifepristone During the COVID-19 Pandemic
- SMFM Responds to the FDA and CDC Recommendation to Pause Administration of the Johnson & Johnson (Janssen) Vaccine
- SMFM Applauds Medicaid Extension from 60 Days to One Year Postpartum
- SMFM Applauds Decision to Offer Janssen COVID Vaccine to Pregnant and Lactating People
- SMFM Applauds House Action on Medicaid Extension
- ACOG and SMFM Issue Statement on WHO Recommendations Regarding COVID-19 Vaccines and Pregnant Individuals
- World’s Leading Clinicians and Researchers to Discuss Best Practices for Predicting, Preventing, and Managing Preeclampsia
- SMFM Appoints Christina Wurster as New CEO
- Physicians, Midwives, and Nurses Encourage Health Care Workers to Get COVID-19 Vaccine
- Leaders in Ob-Gyn Release a Statement Supporting Public Health Measures, Including Vaccination. to Combat COVID-19
- SMFM Responds to the FDA’s Decision to Offer the Newly Approved COVID-19 Vaccine to Pregnant and Lactating People
- SMFM Responds to the FDA's Proposal that Makena and Generic Equivalents be Withdrawn from the Market
- SMFM Joins National Leaders in Women's Health to Call on the Office of the Inspector General to Conduct a Thorough Inquiry to Recent Reports of Medically Unnecessary Hysterectomies Performed without Consent in a Facility Operated by the U.S. Immigration and Customs Enforcement
- How to Protect Patient Information in Ultrasound Images that May be Used in Slide Presentations or Video Files
- SMFM and Other National OBGYN Organizations Issue a Joint Statement on Racism in Medicine
Recent Publications
- SMFM Consult Series #57: Evaluation and management of isolated soft ultrasound markers for aneuploidy in the second trimester
- ACOG-SMFM Practice Advisory: Use of Antenatal Corticosteroids at 22 Weeks of Gestation
- Executive summary: Workshop on Preeclampsia, January 25–26, 2021, cosponsored by the Society for Maternal-Fetal Medicine and the Preeclampsia Foundation
- SMFM Consult Series #56, Hepatitis C in pregnancy—updated guidelines
- Provider Considerations for Engaging in COVID-19 Vaccine Counseling With Pregnant and Lactating Patients
- SMFM Consult Series #59, The use of analgesia and anesthesia for maternal-fetal procedures
- ACOG Practice Bulletin #234, Prediction and Prevention of Spontaneous Preterm Birth
- ACOG Committee Opinion #831, Medically Indicated Late-Preterm and Early-Term Deliveries